跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,132 条关于
“Precigen Inc.”
全部
41,132
临床试验
11,424
药物
1,606
机构
6,170
资讯
21,932
2年前
Precigen Announces Second Quarter and First Half 2024 Financial Results and Business Updates
4个月前
Minimal Residual Disease Pipeline Set for Strategic Expansion by 2026 with Emerging Immunotherapies and Precision Diagnostics
去年
Precigen Stock Surges 48.84% Following Positive FDA Designations for Gene Therapy Pipeline
去年
Precigen Announces Progress on PRGN-2012 for Recurrent Respiratory Papillomatosis
去年
Precigen Secures $125 Million Credit Facility to Advance PAPZIMEOS Commercialization
7年前
Precigen Receives FDA Approval for Papzimeos, First Treatment for Recurrent Respiratory Papillomatosis
去年
FDA Approves Precigen's PAPZIMEOS as First Gene Therapy for Recurrent Respiratory Papillomatosis
去年
Precigen Advances PRGN-2012 for RRP Towards BLA Submission
去年
FDA Grants Priority Review to Precigen's PRGN-2012 for Recurrent Respiratory Papillomatosis
2个月前
Precigen CFO Sells $1.1 Million in Shares Amid Stock Surge and FDA Orphan Drug Designation for Papzimeos
第 1 页,共 2194 页
上一页
下一页